ChemDiv Expands Collaboration for Ratutrelvir Development as a Leading COVID-19 Treatment ChemDiv has announced the extension of its collaboration on CMC services for Ratutrelvir, a promising COVID-19 therapeutic now in Phase 2 trials.

ChemDiv Expands Collaboration for Ratutrelvir Development as a Leading COVID-19 Treatment #USA #San_Diego #Traws_Pharma #Ratutrelvir #ChemDiv

Expert Systems Inc. Advances COVID-19 Treatment with Ratutrelvir Support for Traws Pharma's Phase 2 Trials Expert Systems Inc. continues its support for Traws Pharma as they launch Phase 2 clinical studies for Ratutrelvir, an innovative COVID-19 antiviral drug.

Expert Systems Inc. Advances COVID-19 Treatment with Ratutrelvir Support for Traws Pharma's Phase 2 Trials #United_States #Traws_Pharma #Dover,_Delaware #Expert_Systems_Inc. #Ratutrelvir

Traws Pharma Completes Phase I Trials for New Bird Flu Treatment, Tivoxavir Marboxil Traws Pharma has announced the completion of Phase I trials for Tivoxavir Marboxil, an oral treatment for H5N1 bird flu. This marks a significant step in antiviral development.

Traws Pharma Completes Phase I Trials for New Bird Flu Treatment, Tivoxavir Marboxil #United_States #Newtown #Bird_Flu #Traws_Pharma #Tivoxavir_Marboxil

Breakthrough in H5N1 Bird Flu Treatment: Introducing Tivoxavir Marboxil Expert Systems and Traws Pharma have marked a significant milestone in antiviral drug development, bringing hope for H5N1 bird flu treatment with Tivoxavir Marboxil.

Breakthrough in H5N1 Bird Flu Treatment: Introducing Tivoxavir Marboxil #United_States #San_Diego #Bird_Flu #Traws_Pharma #Tivoxavir_Marboxil

Traws Pharma Secures $72.6 Million Funding to Advance Bird Flu Treatment Development Traws Pharma raises $72.6 million to develop Tivoxavir Marboxil, an oral treatment for H5N1 Bird Flu, amid rising disease concerns.

Traws Pharma Secures $72.6 Million Funding to Advance Bird Flu Treatment Development #USA #Newtown #Traws_Pharma #Tivoxavir_Marboxil #H5N1_Bird_Flu

Traws Pharma's Breakthrough in H5N1 Bird Flu Treatment with Tivoxavir Marboxil Traws Pharma has made significant advancements in developing Tivoxavir Marboxil as a potential treatment for H5N1 bird flu, promising both safety and efficacy.

Traws Pharma's Breakthrough in H5N1 Bird Flu Treatment with Tivoxavir Marboxil #United_States #Traws_Pharma #H5N1 #Tivoxavir_Marboxil #Newtown,_PA